Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 135

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Sputum and serum calprotectin are useful biomarkers during CF exacerbation

Gray, R.D., Imrie, M., Boyd, A.C., Porteous, D., Innes, J.A., Greening, A.P.·2010·Journal of Cystic Fibrosis
DOI 10.1016/j.jcf.2010.01.005
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcf.2010.01.005

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 41

  1. Boucher, 2004, New concepts of the pathogenesis of cystic fibrosis lung disease, Eur Respir J, 23, 146, 10.1183/09031936.03.00057003 · DOI · Paper page
  2. Goss, 2007, Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis, Thorax, 62, 360, 10.1136/thx.2006.060889 · DOI · Paper page
  3. Hiatt, 1999, Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis, Pediatrics, 103, 619, 10.1542/peds.103.3.619 · DOI · Paper page
  4. Aaron, 2004, Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa, Am J Respir Crit Care Med, 169, 811, 10.1164/rccm.200309-1306OC · DOI
  5. Smith, 1988, Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis, J Pediatr, 112, 547, 10.1016/S0022-3476(88)80165-3 · DOI
  6. Ordonez, 2003, Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis, Am J Respir Crit Care Med, 168, 1471, 10.1164/rccm.200306-731OC · DOI
  7. Colombo, 2005, Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy, Pediatr Pulmonol, 40, 15, 10.1002/ppul.20237 · DOI
  8. Marshall, 2004, Pulmonary exacerbations in cystic fibrosis: it's time to be explicit!, Am J Respir Crit Care Med, 169, 781, 10.1164/rccm.2401009 · DOI
  9. Fuchs, 1994, Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group, N Engl J Med, 331, 637, 10.1056/NEJM199409083311003 · DOI · Paper page
  10. Ramsey, 1999, Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group, N Engl J Med, 340, 23, 10.1056/NEJM199901073400104 · DOI · Paper page
  11. Rabin, 2004, Pulmonary exacerbations in cystic fibrosis, Pediatr Pulmonol, 37, 400, 10.1002/ppul.20023 · DOI · Paper page
  12. Sagel, 2001, Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction, Am J Respir Crit Care Med, 164, 1425, 10.1164/ajrccm.164.8.2104075 · DOI · Paper page
  13. Sagel, 2002, Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis, J Pediatr, 141, 811, 10.1067/mpd.2002.129847 · DOI
  14. Salva, 1996, TNF-alpha, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients, Pediatr Pulmonol, 21, 11, 10.1002/(SICI)1099-0496(199601)21:1<11::AID-PPUL2>3.0.CO;2-T · doi:10.1002/(sici)1099-0496(199601)21:1<11::aid-ppul2>3.0.co;2-t
  15. Henig, 2001, Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis, Thorax, 56, 306, 10.1136/thorax.56.4.306 · doi:10.1136/thorax.56.4.306
  16. McGarvey, 2002, Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers, J Cyst Fibros, 1, 269, 10.1016/S1569-1993(02)00098-X · DOI
  17. Sloane, 2005, Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects, Am J Respir Crit Care Med, 172, 1416, 10.1164/rccm.200409-1215OC · doi:10.1164/rccm.200409-1215oc
  18. Regelmann, 1995, Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis, Pediatr Pulmonol, 19, 1, 10.1002/ppul.1950190102 · DOI
  19. Meyer, 2004, Neutrophils, myeloperoxidase, and bronchiectasis in cystic fibrosis: green is not good, J Lab Clin Med, 144, 124, 10.1016/j.lab.2004.05.014 · DOI
  20. Ordonez, 2004, Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis, J Pediatr, 145, 689, 10.1016/j.jpeds.2004.06.054 · doi:10.1016/j.jpeds.2004.06.054
  21. Sagel, 2005, Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis, Pediatr Pulmonol, 39, 224, 10.1002/ppul.20165 · DOI
  22. Downey, 2007, The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis, Pediatr Pulmonol, 42, 216, 10.1002/ppul.20553 · DOI
  23. Mayer-Hamblett, 2007, Association between Pulmonary Function and Sputum Biomarkers in Cystic Fibrosis, Am J Respir Crit Care Med, 175, 822, 10.1164/rccm.200609-1354OC · DOI · Paper page
  24. Macgregor, 2008, Biomarkers for cystic fibrosis lung disease: Application of SELDI-TOF mass spectrometry to BAL fluid, J Cyst Fibros, 7, 352, 10.1016/j.jcf.2007.12.005 · DOI
  25. Gray, 2008, Sputum proteomics in inflammatory and suppurative respiratory diseases, Am J Respir Crit Care Med, 178, 444, 10.1164/rccm.200703-409OC · DOI · Paper page
  26. Wilson, 1975, Studies on cystic fibrosis using isoelectric focusing. I. An assay for detection of cystic fibrosis homozygotes and heterozygote carriers from serum, Pediatr Res, 9, 635, 10.1203/00006450-197508000-00005 · doi:10.1203/00006450-197508000-00005
  27. Dorin, 1987, A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene, Nature, 326, 614, 10.1038/326614a0 · DOI
  28. Raquil, 2008, Blockade of antimicrobial proteins S100A8 and S100A9 inhibits phagocyte migration to the alveoli in streptococcal pneumonia, J Immunol, 180, 3366, 10.4049/jimmunol.180.5.3366 · DOI
  29. Downey, 2007, The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation, Pediatr Pulmonol, 42, 729, 10.1002/ppul.20646 · DOI
  30. Reid, 2007, Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis, Respirology, 12, 63, 10.1111/j.1440-1843.2006.00962.x · doi:10.1111/j.1440-1843.2006.00962.x
  31. Rowe, 2008, Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease, Am J Respir Crit Care Med, 178, 822, 10.1164/rccm.200712-1894OC · DOI
  32. McColley, 2000, Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation, Am J Respir Crit Care Med, 161, 1877, 10.1164/ajrccm.161.6.9905022 · DOI
  33. Pizzichini, 1996, Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination, Eur Respir J, 9, 1174, 10.1183/09031936.96.09061174 · DOI · Paper page
  34. Boussac, 2000, Calcium-dependent secretion in human neutrophils: a proteomic approach, Electrophoresis, 21, 665, 10.1002/(SICI)1522-2683(20000201)21:3<665::AID-ELPS665>3.0.CO;2-U · DOI
  35. Voganatsi, 2001, Mechanism of extracellular release of human neutrophil calprotectin complex, J Leukoc Biol, 70, 130, 10.1189/jlb.70.1.130 · DOI · Paper page
  36. Fagerhol, 2000, Calprotectin, a faecal marker of organic gastrointestinal abnormality, Lancet, 356, 1783, 10.1016/S0140-6736(00)03224-4 · DOI
  37. Costa, 2005, Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease, Gut, 54, 364, 10.1136/gut.2004.043406 · DOI · Paper page
  38. Cohen, 2005, Pathophysiologic consequences following inhibition of a CFTR-dependent developmental cascade in the lung, BMC Dev Biol, 5, 2, 10.1186/1471-213X-5-2 · DOI
  39. Husson, 2005, Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis, J Antimicrob Chemother, 56, 247, 10.1093/jac/dki179 · doi:10.1093/jac/dki179
  40. Ordonez, 2001, Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study, Pediatr Pulmonol, 32, 29, 10.1002/ppul.1085 · DOI
  41. Watt, 2005, Neutrophil cell death, activation and bacterial infection in cystic fibrosis, Thorax, 60, 659, 10.1136/thx.2004.038240 · DOI

Cited by

See all 135

Metadata

Authors
Gray, R. D., Imrie, M., Boyd, A. C., Porteous, D., Innes, J. A., & Greening, A. P.
Venue
Journal of Cystic Fibrosis
Publisher
Elsevier BV
Published
2010-05
Volume
9
Issue
3
Pages
193-198
ISSN
1569-1993
DOI
10.1016/j.jcf.2010.01.005
Cited by
135
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sputum and serum calprotectin are useful biomarkers during CF exacerbation. https://app.cochat.ai/papers/10.1016/j.jcf.2010.01.005
The paper
Gray, R. D., Imrie, M., Boyd, A. C., Porteous, D., Innes, J. A., & Greening, A. P. (2010). Sputum and serum calprotectin are useful biomarkers during CF exacerbation. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2010.01.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.